Legal & General Group
AGL icon

Legal & General Group’s Agilon Health AGL Stock Holding History

Legal & General Group’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$193K Buy
1,805
+694
+62% +$45.5K ﹤0.01% 2563
2026
Q1 		$8.79K Sell
1,111
-807
-42% -$13K ﹤0.01% 3212
2025
Q4 		$33K Sell
1,918
-11,512
-86% -$223K ﹤0.01% 2837
2025
Q3 		$345K Sell
13,430
-411
-3% -$15.5K ﹤0.01% 2533
2025
Q2 		$796K Buy
13,841
+548
+4% +$44K ﹤0.01% 2305
2025
Q1 		$1.44M Sell
13,293
-573
-4% -$49.9K ﹤0.01% 2051
2024
Q4 		$659K Buy
13,866
+338
+2% +$20.4K ﹤0.01% 2367
2024
Q3 		$1.33M Buy
13,528
+194
+1% +$25.1K ﹤0.01% 2129
2024
Q2 		$2.18M Buy
13,334
+1,271
+11% +$181K ﹤0.01% 1910
2024
Q1 		$1.84M Buy
12,063
+104
+0.9% +$17.3K ﹤0.01% 1978
2023
Q4 		$3.75M Sell
11,959
-332
-3% -$120K ﹤0.01% 1666
2023
Q3 		$5.46M Buy
12,291
+15
+0.1% +$6.78K ﹤0.01% 1394
2023
Q2 		$5.32M Buy
12,276
+4,021
+49% +$2.26M ﹤0.01% 1432
2023
Q1 		$4.9M Buy
8,255
+624
+8% +$350K ﹤0.01% 1423
2022
Q4 		$3.08M Buy
7,631
+515
+7% +$242K ﹤0.01% 1673
2022
Q3 		$4.17M Buy
7,116
+41
+0.6% +$24.6K ﹤0.01% 1448
2022
Q2 		$3.86M Buy
7,075
+3,081
+77% +$1.56M ﹤0.01% 1548
2022
Q1 		$2.53M Buy
3,994
+19
+0.5% +$9.79K ﹤0.01% 1885
2021
Q4 		$2.68M Buy
3,975
+3,648
+1,116% +$2.22M ﹤0.01% 1891
2021
Q3 		$215K Buy
327
+47
+17% +$40.1K ﹤0.01% 2667
2021
Q2 		$284K Buy
+280
New +$245K ﹤0.01% 2452

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Legal & General Group's AGL Position: Q2 2026 in Review

Legal & General Group increased its Agilon Health (AGL) stake by 62% in Q2 2026, buying an estimated $45.5K and bringing the position to 1,805 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #2563.

Legal & General Group first reported a position in AGL in Q2 2021 and has held it in 21 quarters since. The position peaked at $5.46M in Q3 2023. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Legal & General Group held 1,805 shares of Agilon Health worth $193K as of Q2 2026.
  • Legal & General Group bought 694 Agilon Health shares in Q2 2026, an estimated $45.5K.
  • Agilon Health made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2563 holding.
  • Legal & General Group first reported a position in Agilon Health in Q2 2021 and has held it in 21 quarters since.
  • Legal & General Group's Agilon Health position peaked at $5.46M in Q3 2023.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.